Solventum's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Solventum's ROA in the third quarter of 2026?
Solventum Corporation achieved a return on average assets (ROA) of 1.1 % in its third quarter of 2026, which is below Solventum's average return on assets, which stands at 7.14%.

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 93 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 609, from total ROA ranking in the second quarter of 2026 at 639.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	-2.51 %	-8.45 %	-6.83 %	-8.82 %	-8.7 %
Y / Y Net Income Change	-	2.22 %	-90.51 %	103.23 %	937.7 %
Net Income (TTM) in million	156	1,434	1,432	1,556	1,524
Return On Assets (TTM)	1.1 %	10.03 %	9.8 %	10.46 %	10.01 %
SOLV's Total Ranking	# 609	# 639	# 577	# 1683	# 1694
Total Assets (TTM) in million	14,165	14,243	14,097	14,294	14,529
Seq. Total Assets Change	-0.55 %	1.04 %	-1.38 %	-1.62 %	-6.61 %
Seq. Net Income Change	-	607.69 %	-79.37 %	-95.02 %	1306.67 %

SOLV's 5 Years Annual ROA >> Back to SOLV Management Effectiveness >> Compare SOLV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 27
Sector	# 94
Overall	# 593

Return On Assets Statistics
High	Average	Low
10.76 %	7.14 %	2.61 %
(Dec 31 2025)		(Jun 30 2025)

Financial Statements
Solventum's Assets	$ 14,165 million	SOLV's Balance sheet
Solventum's Income	$ -12 million	Quarterly SOLV's Income Statement
SOLV's Income by Division		See SOLV's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	-19.97 %	-	-	-	-
Total Assets in million	12,546	15,676	0	0	0
Y / Y Net Income Change	224.84 %	-	-	-	-
Net Income in million	1,556	479	0	0	0
Annual Return On Assets	12.4 %	3.06 %	-	-	-

SOLV's 5 Years Annual ROA >> Back to SOLV Management Effectiveness >> Compare SOLV ROA to its Competitors

Comment on SOLV's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 12.4 % compared to prior year, due to annual net income growth of 224.84 % to $1,556.00 million, and due to decline of value in Solventum's assets by -19.97 % to $12,546.00 million, compared to $12,546.00 a year before.

More Return On Assets Ratios
SOLV's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SOLV's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SOLV's Competitors
Subscribers only: Roa for Solventum's Suppliers
Subscribers only: Return On Assets for SOLV's Customers

You may also want to know
SOLV's Roi	SOLV's Inventory Turnover Ratio	SOLV's Growth Rates	SOLV's Dividend Comparisons
	SOLV's Profitability Ratios	SOLV's Asset Turnover Ratio	SOLV's Dividend Growth
SOLV's Roe	SOLV's Valuation Ratios	SOLV's Financial Strength Ratios	SOLV's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Avantor Inc	2.89 %
Ligand Pharmaceuticals Incorporated	2.74 %
Innovage Holding Corp	2.04 %
Pfizer Inc	1.98 %
Jazz Pharmaceuticals Plc	1.77 %
Icu Medical Inc	1.51 %
Teva Pharmaceutical Industries Limited	1.26 %
Community Health Systems Inc	1.21 %
Biogen Inc	1.13 %
Integra Lifesciences Holdings Corp	0.37 %

Date modified: 2026-11-08T13:46:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.